Vident Advisory LLC Has $1.93 Million Stock Position in Relx Plc $RELX

Key Points

• Vident Advisory LLC increased its stake in RELX PLC by 46% during Q1, now holding 38,232 shares worth approximately $1.93 million.
• Wall Street analysts have upgraded RELX from a "hold" to a "buy" rating, with a consensus rating of "buy" across several firms.
• RELX recently announced a semi-annual dividend of $0.2634 per share, representing a yield of 170%, with a current dividend payout ratio of 28.49%.

Vident Advisory LLC grew its holdings in shares of Relx Plc (NYSE:RELX - Free Report) by 46.0% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 38,232 shares of the technology company's stock after purchasing an additional 12,042 shares during the period. Vident Advisory LLC's holdings in Relx were worth $1,927,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the company. Bank of America Corp DE boosted its stake in Relx by 4.2% during the fourth quarter. Bank of America Corp DE now owns 6,246,462 shares of the technology company's stock valued at $283,714,000 after buying an additional 253,107 shares in the last quarter. Lazard Asset Management LLC boosted its stake in Relx by 1.2% during the fourth quarter. Lazard Asset Management LLC now owns 4,224,334 shares of the technology company's stock valued at $191,868,000 after buying an additional 48,793 shares in the last quarter. Ameriprise Financial Inc. boosted its stake in Relx by 8.3% during the first quarter. Ameriprise Financial Inc. now owns 3,041,132 shares of the technology company's stock valued at $154,129,000 after buying an additional 234,094 shares in the last quarter. Northern Trust Corp boosted its stake in Relx by 9.2% during the first quarter. Northern Trust Corp now owns 2,394,097 shares of the technology company's stock valued at $120,686,000 after buying an additional 202,509 shares in the last quarter. Finally, Captrust Financial Advisors boosted its stake in Relx by 9.6% during the fourth quarter. Captrust Financial Advisors now owns 1,209,743 shares of the technology company's stock valued at $54,947,000 after buying an additional 105,946 shares in the last quarter. Institutional investors own 15.02% of the company's stock.

Relx Trading Up 0.5%

Shares of NYSE:RELX traded up $0.24 during midday trading on Friday, reaching $47.04. The company had a trading volume of 1,524,739 shares, compared to its average volume of 920,496. The company has a debt-to-equity ratio of 2.55, a quick ratio of 0.42 and a current ratio of 0.47. Relx Plc has a 1-year low of $44.19 and a 1-year high of $56.33. The firm has a market cap of $86.29 billion, a price-to-earnings ratio of 25.29, a price-to-earnings-growth ratio of 2.99 and a beta of 0.87. The company has a fifty day simple moving average of $50.62 and a two-hundred day simple moving average of $51.23.

Relx Cuts Dividend

The business also recently declared a semi-annual dividend, which will be paid on Tuesday, September 16th. Investors of record on Friday, August 8th will be given a $0.2634 dividend. The ex-dividend date is Friday, August 8th. This represents a dividend yield of 170.0%. Relx's dividend payout ratio (DPR) is 28.49%.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised Relx from a "hold" rating to a "buy" rating in a research note on Saturday, July 26th. One analyst has rated the stock with a Strong Buy rating and four have given a Buy rating to the stock. According to MarketBeat, Relx presently has an average rating of "Buy".

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.